X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-05 | ODYS | Odysight.Ai Inc. | Y.D. More Investments Ltd | 10% | S - Sale+OE | $3.33 | -324,093 | 1,004,593 | -24% | -$1,079,184 | |||||
| D | 2026-01-05 | SYM | Symbotic Inc. | Krasnow Todd | Dir | S - Sale+OE | $68.63 | -4,000 | 996,115 | 0% | -$274,506 | |||||
| M | 2026-01-05 | PR | Permian Resources Corp | Oliphint Guy M | EVP, CFO | S - Sale | $13.69 | -301,741 | 616,683 | -33% | -$4,129,479 | |||||
| DM | 2026-01-05 | PR | Permian Resources Corp | Shannon Robert Regan | EVP, Chief Accounting Officer | S - Sale+OE | $13.68 | -176,659 | 2,360,667 | -7% | -$2,416,995 | |||||
| DM | 2026-01-05 | PR | Permian Resources Corp | Walter James H | Co-CEO | S - Sale+OE | $13.67 | -777,703 | 13,052,819 | -6% | -$10,634,192 | |||||
| DM | 2026-01-05 | PR | Permian Resources Corp | Hickey William M III | Co-CEO | S - Sale+OE | $13.67 | -777,705 | 13,277,817 | -6% | -$10,634,217 | |||||
| DM | 2026-01-05 | PR | Permian Resources Corp | Bell John Charles | EVP, GC | S - Sale+OE | $13.68 | -176,648 | 1,729,685 | -9% | -$2,416,845 | |||||
| M | 2026-01-02 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $1.79 | +647,505 | 0 | -100% | +$1,155,954 | |||||
| M | 2025-12-30 | NYC | American Strategic Investment Co. | Schorsch Nicholas S | 10% | P - Purchase | $8.63 | +4,486 | 1,600,033 | 0% | +$38,727 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Officer | S - Sale | $1.97 | -14,905 | 216,839 | -6% | -$29,436 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Siemers Eric | Chief Medical Officer | S - Sale | $1.96 | -10,834 | 159,464 | -6% | -$21,277 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Oconnell Daniel Joseph | CEO | S - Sale | $1.98 | -47,506 | 619,982 | -7% | -$94,176 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale | $1.98 | -26,668 | 134,459 | -17% | -$52,690 | |||||
| M | 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Barton Russell | COO | S - Sale | $1.97 | -9,318 | 126,799 | -7% | -$18,325 | |||||
2026-01-05 | TECTP | Tectonic Financial, Inc. | Sherman A Haag | CEO, 10% | S - Sale | $5.70 | -20,000 | 2,101,000 | -1% | -$114,000 | ||||||
2026-01-05 | SNAP | Snap Inc | Spiegel Evan | CEO, 10% | S - Sale | $8.25 | -1,220,165 | 28,515,118 | -4% | -$10,066,361 | ||||||
2026-01-06 | CREX | Creative Realities, Inc. | Slipstream Communications, LLC | 10% | S - Sale | $2.52 | -1,425,485 | 0 | -100% | -$3,592,222 | ||||||
| AD | 2025-12-22 | ADPT | Adaptive Biotechnologies Corp | Lo Francis | Chief People Officer | S - Sale+OE | $17.50 | -4,394 | 318,478 | -1% | -$76,895 | |||||
2026-01-05 | ADPT | Adaptive Biotechnologies Corp | Robins Chad M | CEO, COB | S - Sale | $15.59 | -124,998 | 2,584,243 | -5% | -$1,948,719 | ||||||
2026-01-05 | TECTP | Tectonic Financial, Inc. | Sanders Thomas R | Dir | S - Sale | $23.57 | -172,480 | 42,620 | -80% | -$4,065,414 | ||||||
| M | 2026-01-06 | CCB | Coastal Financial Corp | Sprink Eric M | CEO | S - Sale | $116.69 | -11,000 | 184,969 | -6% | -$1,283,594 | |||||
2026-01-05 | TECTP | Tectonic Financial, Inc. | Clapp Steven B | Dir | S - Sale | $23.57 | -172,480 | 42,620 | -80% | -$4,065,414 | ||||||
| M | 2026-01-05 | ANTX | An2 Therapeutics, Inc. | Day Lucy | CFO | S - Sale | $1.01 | -8,807 | 75,363 | -10% | -$8,883 | |||||
| M | 2026-01-05 | ANTX | An2 Therapeutics, Inc. | Prior Stephen David | Chief Strategy Officer | S - Sale | $1.01 | -6,462 | 59,086 | -10% | -$6,507 | |||||
| M | 2026-01-05 | ANTX | An2 Therapeutics, Inc. | Chanda Sanjay | Chief Development Officer | S - Sale | $1.01 | -9,251 | 75,823 | -11% | -$9,332 | |||||
| M | 2017-03-31 | CDTX | Cidara Therapeutics, Inc. | Stein Jeffrey | Pres, CEO | P - Purchase | $79.55 | +4,262 | 75,640 | +6% | +$339,040 | |||||
| M | 2026-01-05 | ANTX | An2 Therapeutics, Inc. | Eizen Joshua M | See Remarks | S - Sale | $1.00 | -24,854 | 152,499 | -14% | -$24,962 | |||||
| M | 2026-01-05 | TPVG | Triplepoint Venture Growth Bdc Corp. | Labe James | CEO | P - Purchase | $6.66 | +74,000 | 2,150,634 | +4% | +$492,874 | |||||
| M | 2026-01-05 | TPVG | Triplepoint Venture Growth Bdc Corp. | Srivastava Sajal | Pres, CIO | P - Purchase | $6.66 | +74,000 | 2,217,956 | +3% | +$492,874 | |||||
| DM | 2026-01-05 | PPTA | Perpetua Resources Corp. | Sternhell Alexander McLeod | Dir | S - Sale+OE | $27.09 | -13,148 | 16,352 | -45% | -$356,192 | |||||
| DM | 2026-01-05 | PPTA | Perpetua Resources Corp. | Robison Chris J | Dir | S - Sale+OE | $26.32 | -13,701 | 85,799 | -14% | -$360,669 | |||||
| DM | 2026-01-05 | PPTA | Perpetua Resources Corp. | Malmen Jeffrey L | Dir | S - Sale+OE | $26.42 | -15,181 | 14,319 | -51% | -$401,018 | |||||
2026-01-05 | DKL | Delek Logistics Partners, LP | Spiegel Reuven | EVP, DKL | S - Sale | $46.99 | -250 | 22,990 | -1% | -$11,748 | ||||||
| D | 2026-01-05 | PPTA | Perpetua Resources Corp. | Lyon McKinsey Margaret | (See remarks (4)) | S - Sale+OE | $26.61 | -32,490 | 96,664 | -25% | -$864,559 | |||||
| D | 2026-01-05 | CRWV | Coreweave, Inc. | McBee Brannin | Chief Development Officer | S - Sale+OE | $79.28 | -8,835 | 58,800 | -13% | -$700,454 | |||||
| DM | 2026-01-05 | PPTA | Perpetua Resources Corp. | Dean Robert Alan | Dir | S - Sale+OE | $26.64 | -5,708 | 22,302 | -20% | -$152,070 | |||||
| D | 2026-01-05 | CRWV | Coreweave, Inc. | McBee Brannin | Chief Development Officer | S - Sale+OE | $79.28 | -27,000 | 0 | -100% | -$2,140,616 | |||||
| D | 2026-01-05 | CRWV | Coreweave, Inc. | McBee Brannin | Chief Development Officer | S - Sale+OE | $79.28 | -130,835 | 248,664 | -34% | -$10,372,925 | |||||
| M | 2026-01-05 | PLAB | Photronics Inc | Lee Kang Jyh | Dir | S - Sale | $34.66 | -20,000 | 455,850 | -4% | -$693,100 | |||||
2026-01-06 | PLAB | Photronics Inc | Paladino Mary | Dir | S - Sale | $35.11 | -11,250 | 23,820 | -32% | -$394,988 | ||||||
2026-01-06 | PLAB | Photronics Inc | Tyson Mitchell G | Dir | S - Sale | $35.21 | -5,000 | 43,199 | -10% | -$176,050 | ||||||
| A | 2026-01-06 | TPL | Texas Pacific Land Corp | Horizon Kinetics Asset Management LLC | 10% | P - Purchase | $296.79 | +1 | 25,268 | 0% | +$297 | |||||
| M | 2026-01-05 | SEV | Aptera Motors Corp | Johnson Michael Edious | 10% | S - Sale | $4.60 | -22,000 | 5,062,776 | 0% | -$101,127 | |||||
| A | 2025-11-17 | AEE | Ameren Corp | Flores Rafael | Dir | S - Sale | $105.32 | -626 | 13,772 | -4% | -$65,930 | |||||
| D | 2026-01-05 | LPTH | Lightpath Technologies Inc | North Run Strategic Opportunities Fund I, LP | Dir, 10% | S - Sale+OE | $11.72 | -770,321 | 2,728,968 | -22% | -$9,028,162 | |||||
| D | 2026-01-06 | NTSK | Netskope Inc | Del Matto Andrew H | CFO | S - Sale+OE | $17.16 | -49,875 | 41,493 | -55% | -$855,765 | |||||
| DM | 2026-01-06 | NTSK | Netskope Inc | Beri Sanjay | CEO, COB | S - Sale+OE | $17.20 | -210,076 | 0 | -100% | -$3,612,827 | |||||
| M | 2026-01-05 | WRB | Berkley W R Corp | Mitsui Sumitomo Insurance Co Ltd | 10% | P - Purchase | $69.61 | +681,218 | 51,445,463 | +1% | +$47,416,247 | |||||
| D | 2026-01-05 | CBLL | Ceribell, Inc. | Foehr David | SVP, Finance, PAO | S - Sale+OE | $22.60 | -5,556 | 18,900 | -23% | -$125,566 | |||||
2026-01-06 | PUBM | Pubmatic, Inc. | Goel Amar K. | COB, Chief Innovation Off, 10% | S - Sale | $8.73 | -7,158 | 12,496 | -36% | -$62,510 | ||||||
| D | 2026-01-05 | CVX | Chevron Corp | Wirth Michael K | COB, CEO | S - Sale+OE | $162.99 | -320,700 | 50,969 | -86% | -$52,271,978 | |||||
2026-01-06 | PUBM | Pubmatic, Inc. | Klimenko Paulina | Chief Growth Officer | S - Sale | $8.73 | -12,315 | 51,780 | -19% | -$107,509 | ||||||
| DM | 2026-01-05 | AXSM | Axsome Therapeutics, Inc. | Tabuteau Herriot | CEO, 10% | S - Sale+OE | $171.30 | -139,414 | 7,351,729 | -2% | -$23,881,618 | |||||
2026-01-05 | WDAY | Workday, Inc. | Eschenbach Carl M. | CEO | S - Sale | $210.00 | -3,125 | 651,308 | 0% | -$656,250 | ||||||
| D | 2026-01-05 | CVX | Chevron Corp | Bonner Eimear P | CFO | S - Sale+OE | $165.05 | -28,334 | 4,774 | -86% | -$4,676,527 | |||||
2026-01-05 | FFIV | F5, Inc. | Fountain Thomas Dean | EVP Global Services, Strategy | S - Sale | $263.79 | -1,110 | 13,623 | -8% | -$292,807 | ||||||
| D | 2026-01-05 | MOBX | Mobix Labs, Inc | Samini Keyvan | Pres, CFO, Dir | S - Sale+OE | $0.32 | -211,672 | 2,989,865 | -7% | -$68,645 | |||||
| D | 2026-01-05 | NAMS | Newamsterdam Pharma Co N.V. | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | S - Sale+OE | $33.25 | -6,000 | 98,981 | -6% | -$199,500 | |||||
| D | 2026-01-05 | NAMS | Newamsterdam Pharma Co N.V. | Kooij Louise Frederika | Chief Accounting Officer | S - Sale+OE | $33.25 | -2,647 | 24,353 | -10% | -$88,013 | |||||
| D | 2026-01-05 | NAMS | Newamsterdam Pharma Co N.V. | Somaiya Mayur Ian | CFO | S - Sale+OE | $33.25 | -5,118 | 58,382 | -8% | -$170,174 | |||||
2026-01-05 | TEM | Tempus Ai, Inc. | Fukushima Ryan | COO | S - Sale | $64.26 | -5,000 | 852,754 | -1% | -$321,300 | ||||||
2026-01-05 | GRND | Grindr Inc. | Lu James Fu Bin | 10% | S - Sale | $13.53 | -92,071 | 22,153,629 | 0% | -$1,245,721 | ||||||
2026-01-05 | META | Meta Platforms, Inc. | Olivan Javier | COO | S - Sale | $650.41 | -517 | 122,419 | 0% | -$336,262 | ||||||
| D | 2026-01-07 | MUSA | Murphy USA Inc. | West Malynda K | Pres, CEO | S - Sale+OE | $425.00 | -4,051 | 118,262 | -3% | -$1,721,675 | |||||
| M | 2025-12-30 | PAR | Par Technology Corp | Voss Capital, LP | 10% | P - Purchase | $36.24 | +196,035 | 4,603,898 | +4% | +$7,103,702 | |||||
| D | 2026-01-05 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale+OE | $21.27 | -79,000 | 1,110,336 | -7% | -$1,680,048 | |||||
| DM | 2026-01-05 | AIP | Arteris, Inc. | Alpern Paul L | VP, GC | S - Sale+OE | $16.56 | -6,818 | 57,650 | -11% | -$112,937 | |||||
| D | 2026-01-05 | CVX | Chevron Corp | Knowles Alana K | Controller | S - Sale+OE | $165.05 | -7,956 | 14,131 | -36% | -$1,313,138 | |||||
| D | 2026-01-05 | QS | Quantumscape Corp | Holme Timothy | CTO | S - Sale+OE | $11.28 | -211,362 | 1,251,383 | -14% | -$2,383,745 | |||||
2026-01-05 | QS | Quantumscape Corp | Straubel Jeffrey B | Dir | S - Sale | $11.28 | -27,106 | 239,722 | -10% | -$305,691 | ||||||
| D | 2026-01-05 | AFRM | Affirm Holdings, Inc. | Levchin Max R | CEO, 10% | S - Sale+OE | $80.62 | -666,666 | 735,294 | -48% | -$53,747,814 | |||||
| D | 2026-01-05 | AFRM | Affirm Holdings, Inc. | O'Hare Robert | CFO | S - Sale+OE | $80.00 | -36,401 | 1,368 | -96% | -$2,912,080 | |||||
| M | 2025-12-30 | FLYW | Flywire Corp | Voss Capital, LP | 10% | P - Purchase | $14.17 | +226,112 | 12,320,000 | +2% | +$3,203,278 | |||||
2026-01-07 | GSAT | Globalstar, Inc. | Jacobs Paul E | CEO | S - Sale | $65.80 | -845 | 1,175,230 | 0% | -$55,601 | ||||||
| D | 2026-01-05 | MOVE | Movano Inc. | Mastrototaro John | CEO | S - Sale+OE | $8.21 | -2,514 | 4,430 | -36% | -$20,640 | |||||
2026-01-05 | ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | S - Sale | $28.98 | -2,490 | 94,120 | -3% | -$72,166 | ||||||
2026-01-05 | MRVL | Marvell Technology, Inc. | Casper Mark | EVP, GC | S - Sale | $93.08 | -5,000 | 36,581 | -12% | -$465,400 | ||||||
| M | 2026-01-05 | PMCB | Pharmacyte Biotech, Inc. | Silverman Joshua | CEO, Pres | P - Purchase | $0.80 | +100,000 | 466,250 | +27% | +$80,476 | |||||
| M | 2026-01-05 | PMCB | Pharmacyte Biotech, Inc. | Schechter Jonathan | Dir | P - Purchase | $0.80 | +60,000 | 192,500 | +45% | +$48,232 | |||||
| M | 2026-01-05 | GTE | Gran Tierra Energy Inc. | Lm Asset (Im) Inc. | 10% | P - Purchase | $4.02 | +180,000 | 4,301,750 | +4% | +$724,346 | |||||
| D | 2026-01-05 | NCNO | Ncino, Inc. | Desmond Sean | CEO, Pres | S - Sale+OE | $24.51 | -7,331 | 618,597 | -1% | -$179,683 | |||||
| M | 2026-01-05 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $6.04 | -12,918 | 753,562 | -2% | -$78,011 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Pelish Henry E. | Chief Scientific Officer | S - Sale+OE | $97.24 | -5,160 | 83,388 | -6% | -$501,753 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Noci Darlene | Chief Development Officer | S - Sale+OE | $97.25 | -7,417 | 58,117 | -11% | -$721,320 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Miller Deborah Ann | GC | S - Sale+OE | $97.26 | -6,952 | 59,634 | -10% | -$676,158 | |||||
2025-12-30 | ASTI | Ascent Solar Technologies, Inc. | Forrest Reynolds T. | Dir | S - Sale | $4.62 | -521 | 312 | -63% | -$2,407 | ||||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Turner Christopher Durant | Chief Medical Officer | S - Sale+OE | $97.25 | -7,417 | 72,630 | -9% | -$721,320 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Balcom Alexandra | CFO | S - Sale+OE | $97.25 | -7,417 | 99,233 | -7% | -$721,320 | |||||
| DM | 2026-01-05 | NUVL | Nuvalent, Inc. | Porter James Richard | Pres, CEO | S - Sale+OE | $97.26 | -27,433 | 324,879 | -8% | -$2,668,260 | |||||
2026-01-06 | WDAY | Workday, Inc. | Kazmaier Gerrit S | Pres, Prod., Tech. | S - Sale | $208.73 | -3,759 | 105,167 | -3% | -$784,626 | ||||||
2026-01-05 | WDAY | Workday, Inc. | Enslin Robert | Pres, CCO | S - Sale | $210.17 | -22,185 | 106,330 | -17% | -$4,662,713 | ||||||
2025-12-01 | ALTIX | Align Alternative Access Fund | Leinan Jeffrey | Dir | P - Purchase | $10.20 | +68,627 | 96,330 | +248% | +$700,000 | ||||||
2026-01-06 | WDAY | Workday, Inc. | Rowe Zane | CFO | S - Sale | $208.75 | -6,000 | 159,158 | -4% | -$1,252,492 | ||||||
2026-01-06 | WDAY | Workday, Inc. | Sauer Richard Harry | GC, Secty | S - Sale | $210.00 | -1,130 | 85,398 | -1% | -$237,300 | ||||||
2025-11-03 | ALTIX | Align Alternative Access Fund | Leinan Jeffrey | Dir | P - Purchase | $10.10 | +27,703 | 27,703 | New | +$279,800 | ||||||
| M | 2026-01-05 | HOWL | Werewolf Therapeutics, Inc. | Evnin Luke | Dir | S - Sale | $0.65 | -71,054 | 2,401,243 | -3% | -$45,882 | |||||
| D | 2026-01-05 | CRNX | Crinetics Pharmaceuticals, Inc. | Kalofonos Isabel | Chief Commercial Officer | S - Sale+OE | $55.00 | -2,500 | 834 | -75% | -$137,500 | |||||
| D | 2026-01-05 | UPST | Upstart Holdings, Inc. | Darling Scott | GC | S - Sale+OE | $50.00 | -1,000 | 110,033 | -1% | -$50,000 | |||||
2026-01-07 | CLOV | Clover Health Investments, Corp. /De | Reynoso Jamie L. | CEO, Medicare Advantage | S - Sale | $2.53 | -2,102 | 2,757,029 | 0% | -$5,318 | ||||||
2026-01-06 | ZSPC | Zspace, Inc. | Deoliveira Erick | CFO | S - Sale | $0.52 | -7,839 | 40,497 | -16% | -$4,092 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |